BiosimulantBiosimulant
Docs
Search labs...
Sign inGet Started

Al-Tuwairqi2020 - Dynamics of cancer virotherapy with immune response Lab

About lab

This ordinary differential equation model of the role of the immune response in cancer virotherapy dynamics is described in the publication:Al-Tuwairqi, S.M., Al-Johani, N.O., Simbawa, E.A. It can be used to explore immune response dynamics and compare pathway-level behavior across conditions.

Runtime

Duration10
Comms Step1

Runs

Total0
Completed0
Failed0

Metadata

Packageal-tuwairqi2020-dynamics-of-cancer-virotherapy-with-immune-respo
Created2026-05-15
Updated2026-05-15
immunologysbmlbiomodels_ebifaithfulcuratedvisualisation

Manifest

{
  "io": {
    "inputs": [
      {
        "name": "initial_uninfected_cancer_cells",
        "label": "Initial Uninfected Cancer Cells",
        "units": "native source value",
        "default": 0.5,
        "maps_to": "immunology_sbml_al_tuwairqi2020_dynamics_of_cancer_virotherapy_w_biomd0000001035_model.initial_uninfected_cancer_cells",
        "description": "Initial Uninfected Cancer Cells. Sets the initial value of bundled SBML species `uninfected_cancer_cells`."
      },
      {
        "name": "initial_infected_cancer_cells",
        "label": "Initial Infected Cancer Cells",
        "units": "native source value",
        "default": 0,
        "maps_to": "immunology_sbml_al_tuwairqi2020_dynamics_of_cancer_virotherapy_w_biomd0000001035_model.initial_infected_cancer_cells",
        "description": "Initial Infected Cancer Cells. Sets the initial value of bundled SBML species `infected_cancer_cells`."
      },
      {
        "name": "initial_free_virus",
        "label": "Initial Free Virus",
        "units": "native source value",
        "default": 0.01,
        "maps_to": "immunology_sbml_al_tuwairqi2020_dynamics_of_cancer_virotherapy_w_biomd0000001035_model.initial_free_virus",
        "description": "Initial Free Virus. Sets the initial value of bundled SBML species `free_virus`."
      },
      {
        "name": "initial_immune_cells",
        "label": "Initial Immune Cells",
        "units": "native source value",
        "default": 0.01,
        "maps_to": "immunology_sbml_al_tuwairqi2020_dynamics_of_cancer_virotherapy_w_biomd0000001035_model.initial_immune_cells",
        "description": "Initial Immune Cells. Sets the initial value of bundled SBML species `immune_cells`."
      },
      {
        "name": "tumor_growth_rate",
        "label": "Tumor Growth Rate",
        "units": "native source value",
        "default": 0.36,
        "maps_to": "immunology_sbml_al_tuwairqi2020_dynamics_of_cancer_virotherapy_w_biomd0000001035_model.tumor_growth_rate",
        "description": "Tumor Growth Rate. Sets bundled SBML parameter `r_1`."
      },
      {
        "name": "cancer_cell_infection_rate",
        "label": "Cancer Cell Infection Rate",
        "units": "native source value",
        "default": 0.5,
        "maps_to": "immunology_sbml_al_tuwairqi2020_dynamics_of_cancer_virotherapy_w_biomd0000001035_model.cancer_cell_infection_rate",
        "description": "Cancer Cell Infection Rate. Sets bundled SBML parameter `a`."
      },
      {
        "name": "uninfected_cancer_cell_killing_death_rate",
        "label": "Uninfected Cancer Cell Killing Death Rate",
        "units": "native source value",
        "default": 0.1278,
        "maps_to": "immunology_sbml_al_tuwairqi2020_dynamics_of_cancer_virotherapy_w_biomd0000001035_model.uninfected_cancer_cell_killing_death_rate",
        "description": "Uninfected Cancer Cell Killing Death Rate. Sets bundled SBML parameter `d_1`."
      },
      {
        "name": "infected_cancer_cell_killing_death_rate",
        "label": "Infected Cancer Cell Killing Death Rate",
        "units": "native source value",
        "default": 0.48,
        "maps_to": "immunology_sbml_al_tuwairqi2020_dynamics_of_cancer_virotherapy_w_biomd0000001035_model.infected_cancer_cell_killing_death_rate",
        "description": "Infected Cancer Cell Killing Death Rate. Sets bundled SBML parameter `c`."
      },
      {
        "name": "virus_release_rate",
        "label": "Virus Release Rate",
        "units": "native source value",
        "default": 2,
        "maps_to": "immunology_sbml_al_tuwairqi2020_dynamics_of_cancer_virotherapy_w_biomd0000001035_model.virus_release_rate",
        "description": "Virus Release Rate. Sets bundled SBML parameter `b`."
      }
    ],
    "outputs": [
      {
        "name": "uninfected_cancer_cells",
        "maps_to": "immunology_sbml_al_tuwairqi2020_dynamics_of_cancer_virotherapy_w_biomd0000001035_model.uninfected_cancer_cells"
      },
      {
        "name": "infected_cancer_cells",
        "maps_to": "immunology_sbml_al_tuwairqi2020_dynamics_of_cancer_virotherapy_w_biomd0000001035_model.infected_cancer_cells"
      },
      {
        "name": "free_virus",
        "maps_to": "immunology_sbml_al_tuwairqi2020_dynamics_of_cancer_virotherapy_w_biomd0000001035_model.free_virus"
      },
      {
        "name": "immune_cells",
        "maps_to": "immunology_sbml_al_tuwairqi2020_dynamics_of_cancer_virotherapy_w_biomd0000001035_model.immune_cells"
      },
      {
        "name": "state",
        "maps_to": "immunology_sbml_al_tuwairqi2020_dynamics_of_cancer_virotherapy_w_biomd0000001035_model.state"
      },
      {
        "name": "summary",
        "maps_to": "immunology_sbml_al_tuwairqi2020_dynamics_of_cancer_virotherapy_w_biomd0000001035_model.summary"
      },
      {
        "name": "species_labels",
        "maps_to": "immunology_sbml_al_tuwairqi2020_dynamics_of_cancer_virotherapy_w_biomd0000001035_model.species_labels"
      }
    ]
  },
  "title": "Al-Tuwairqi2020 - Dynamics of cancer virotherapy with immune response Lab",
  "models": [
    {
      "path": "owned/models/immunology_sbml_al_tuwairqi2020_dynamics_of_cancer_virotherapy_w_biomd0000001035_model",
      "alias": "immunology_sbml_al_tuwairqi2020_dynamics_of_cancer_virotherapy_w_biomd0000001035_model",
      "provenance": {
        "owned_path": "owned/models/immunology_sbml_al_tuwairqi2020_dynamics_of_cancer_virotherapy_w_biomd0000001035_model"
      }
    },
    {
      "path": "owned/models/visualisation",
      "alias": "visualisation",
      "provenance": {
        "owned_path": "owned/models/visualisation"
      }
    }
  ],
  "wiring": [
    {
      "to": [
        "visualisation.immunology_sbml_al_tuwairqi2020_dynamics_of_cancer_virotherapy_w_biomd0000001035_model_state"
      ],
      "from": "immunology_sbml_al_tuwairqi2020_dynamics_of_cancer_virotherapy_w_biomd0000001035_model.state"
    },
    {
      "to": [
        "visualisation.immunology_sbml_al_tuwairqi2020_dynamics_of_cancer_virotherapy_w_biomd0000001035_model_summary"
      ],
      "from": "immunology_sbml_al_tuwairqi2020_dynamics_of_cancer_virotherapy_w_biomd0000001035_model.summary"
    },
    {
      "to": [
        "visualisation.immunology_sbml_al_tuwairqi2020_dynamics_of_cancer_virotherapy_w_biomd0000001035_model_species_labels"
      ],
      "from": "immunology_sbml_al_tuwairqi2020_dynamics_of_cancer_virotherapy_w_biomd0000001035_model.species_labels"
    }
  ],
  "runtime": {
    "duration": 10,
    "initial_inputs": {},
    "communication_step": 1
  },
  "description": "This ordinary differential equation model of the role of the immune response in cancer virotherapy dynamics is described in the publication:Al-Tuwairqi, S.M., Al-Johani, N.O., Simbawa, E.A. It can be used to explore immune response dynamics and compare pathway-level behavior across conditions.",
  "schema_version": "2.0"
}

Sign in to start your own run. Public-lab history stays visible here.

Select a run from History to view its results.